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Abstract 
Background: From ancient times, marine algae have emerged as alternative medicine and foods, contains the rich 
source of natural products like proteins, vitamins, and secondary metabolites, especially Chlorella vulgaris (C. vulgaris) 
contains numerous anti-inflammatory, antioxidants and wound healing substances. Type 2 diabetes mellitus is closely 
associated with adipogenesis and their factors. Hence, we aimed to investigate the chemical constituents and adipo-
genic modulatory properties of C. vulgaris in 3T3-L1 pre-adipocytes.
Results: We analysed chemical constituents in ethanolic extract of C. vulgaris (EECV) by LC–MS. Results revealed that 
the EECV contains few triterpenoids and saponin compounds. Further, the effect of EECV on lipid accumulation along 
with genes and proteins expressions which are associated with adipogenesis and lipogenesis were evaluated using 
oil red O staining, qPCR and western blot techniques. The data indicated that that EECV treatment increased differen-
tiation and lipid accumulation in 3T3-L1 cells, which indicates positive regulation of adipogenic and lipogenic activity. 
These increases were associated with up-regulation of PPAR-γ2, C/EBP-α, adiponectin, FAS, and leptin mRNA and 
protein expressions. Also, EECV treatments increased the concentration of glycerol releases as compared with control 
cells. Troglitazone is a PPAR-γ agonist that stimulates the PPAR-γ2, adiponectin, and GLUT-4 expressions. Similarly, EECV 
treatments significantly upregulated PPAR-γ2, adiponectin, GLUT-4 expressions and glucose utilization. Further, EECV 
treatment decreased AMPK-α expression as compared with control and metformin treated cells.
Conclusion: The present research findings confirmed that the EECV effectively modulates the lipid accumulation and 
differentiation in 3T3-L1 cells through AMPK-α mediated signalling pathway.
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Background
Adipogenesis is the process which converts the pre-
adipocyte into adipocyte through various mechanisms. 
In circumstances of positive energy balance, increased 
energy storage through the conversion of adipocyte from 
pre-adipocyte by the adipogenesis process [1, 2]. Adipo-
cytes are mainly involved in the maintenance of energy 
balance and lipid homoeostasis by releasing free fatty 
acids and storing triacylglycerols in response to changes 
in energy demands. For this reason, many research-
ers have been focused on the increase of adipose tissue 
mass (hyperplasia) and size of adipocytes (hypertrophy) 
[3]. Animal and human model studies showed that the 
metabolic disorder of type 2 diabetes mellitus is closely 
associated with decreased adipogenesis and adipogenic 
factors [4]. Insufficient amounts of adipose tissue can 
result in inadequate free fatty acids storage, which lead-
ing to increasing plasma levels of free fatty acids, and a 
resultant increased fat deposition in muscle and liver, 
which ultimately leads to make insulin resistance and 
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clinical type 2 diabetes [5]. Numerous identified adipo-
genic factors are involved in the adipogenesis. Among 
these, peroxisome proliferator—activated receptor-γ2 
(PPARγ2), and CCAAT/enhancer binding protein-α (C/
EBP-α) plays an important role in adipocyte differen-
tiation and lipid accumulation. Further, the activation of 
these two factors can stimulate adiponectin, adipogenin, 
leptin, glucose transporter-4 (GLUT-4), fatty acid syn-
thase (FAS), and adipocyte binding protein (aP2) and 
other gene expression which are associated with lipogen-
esis and adipogenesis [6]. AMP-activated protein kinase 
(AMPK) is a hetero-trimer complex, which acts as a sen-
sor of cellular energy [7]. It activated during stresses that 
deplete the cellular ATP and phosphorylate the catalytic 
alpha subunit on Thr172 by an upstream kinase. AMP-
activated protein kinase is getting activated during the 
lipolysis process in adipocyte [8–10].
Natural marine products are much important resources 
for chemical diversity. Recently, numbers of clinical tri-
als have been conducted on these marine products. From 
ancient times, marine algae have emerged as an alterna-
tive medicine and foods in many Asian countries such 
as South Korea, Japan and China etc. [11]. Chlorella is 
potent source for protein, lipid soluble vitamins, cho-
line, and dietary fiber. It contains approximately 60 % of 
protein. The amino acid quantity and nutritional com-
position of chlorella are similar to egg nutrition’s [12, 13] 
and it has many biological properties such as promoting 
growth rate of animals, production of cytokine and stim-
ulating the immune function [14]. Many studies reported 
that the Chlorella vulgaris prevents the oxidative stress in 
mice and stress mediated ulcer [15]. Further, it has anti-
lipidemic and anti-atherosclerotic activity [16]. In addi-
tion, C. vulgaris prevents dyslipidemia in wistar rats [17]. 
The present study, we investigated the impact of etha-
nolic extract of C. vulgaris on adipocyte viability and dif-
ferentiation in 3T3-L1 cells as a model system.
Results
Cytotoxicity effect of EECV on 3T3‑L1 pre‑adipocyte
3T3-L1 cells were treated with various concentrations (5, 
10, 15, 20, 25, 50 and 100 μg/ml) of EECV for 48 h. EECV 
treatment did not affect the pre-adipocyte viability up to 
25  μg/ml. However, further increment (50 and 100  μg/
ml) exhibited slight cytotoxic effects on the 3T3-L1 cells 
as compared with control. Therefore, we considered safe 
dosage ranges of EECV were from 5 to 25 μg/ml for fur-
ther experiment (Fig. 1).
EECV enhances differentiation and lipid accumulation 
in adipocyte
Microscopic observation revealed that the 3T3-L1 cells 
were differentiated into mature adipocyte after addition 
of differentiation induction medium. This differen-
tiation was enhanced by the EECV treatment (Fig.  2A). 
The prior concentration 5 and 10 μg/ml of EECV treat-
ment did not influence the adipocyte differentiation. The 
maximum numbers of mature spherical shape adipocyte 
were observed at a concentration of 25  μg/ml of EECV. 
The oil Red O staining results showed greater intracel-
lular lipid accumulation in the cells treated with EECV 
than the control cells (Fig.  2B). The absorbance of the 
dye extracted from cells showed higher in EECV treated 
adipocyte as compared with control adipocyte (Fig. 2C). 
EECV treated adipocyte showed the higher amount 
of glycerol releases than the control cells (p  ≤  0.05) 
(Fig. 2D).
EECV up‑regulates key transcriptional adipogenic 
and lipogenic gene expression
Further, we investigated the effect of EECV on the adi-
pogenesis-related key transcriptional and other-factors 
using the qPCR technique. Figure 3 shows, EECV treat-
ment increased PPARγ2, C/EBP-α, adiponectin, FAS, and 
leptin mRNA expression as compared with control cell. 
Further, we confirmed the protein expression of PPARγ2 
and C/EBP-α by western blot technique. These results 
evidenced that the EECV upregulates the PPARγ2 and C/
EBP-α protein expressions (Fig. 4).
EECV downregulates AMPK‑α activation and upregulates 
of PPARγ2 protein expression
The adipocyte treated with EECV exhibited downregu-
lation of AMP-activated protein kinase (pAMPK) and 
upregulation of PPARγ2 as compared with control cells. 
Metformin is an agonist for AMPK, which increased 
AMPK-α and decreased PPARγ2 expression in adipo-
cyte (Fig.  5A). Further, metformin mediated activation 
of AMPK-α was abolished by the EECV treatment. It 
Fig. 1 Cytotoxic effects of EECV on 3T3-L1 cells. 3T3-L1 cells were 
treated with different concentrations (5, 10, 15, 20, 25, 50 and 100 μg/
ml) of EECV for 48 h. The concentration at 50 and 100 μg/ml exhibited 
slight cytotoxic effects on the 3T3-L1 cells
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indicates that EECV treatment stimulates adipocyte dif-
ferentiation via upregulation of PPARγ2 by inhibition of 
AMPK-α mediated signal pathway (Fig. 5B).
EECV increased glucose utilization
Troglitazone (TZD) is an agonist for PPARγ, which stim-
ulates PPARγ expression in the adipocyte. Here, adipo-
cyte treated with troglitazone (5 µM) for 48 h increased 
PPARγ2 expression and lipid accumulation as compared 
with control cells. Further, it increased adiponectin and 
GLUT-4 mRNA expression. Similarly, EECV treatment 
increased PPARγ, adiponectin and GLUT-4 mRNA 
expression as compared with control cells (Fig.  6A). 
Further, we confirmed the protein expression patterns 
of PPARγ2 and adiponectin in TZD and EECV treated 
adipocyte; it revealed that the EECV stimulates PPARγ 
and adiponectin protein expression like TZD treatment 
(Fig.  6B). EECV stimulates lipid accumulation in adipo-
cyte similar to troglitazone as compared with control 
cells (Fig. 6C). In addition, adipocyte treated with EECV 
significantly increased glucose utilisation as compared 
with control cells. This utilisation may be due to increas-
ing of adiponectin and GLUT-4 level by the EECV treat-
ment. These results were comparable with troglitazone 
and insulin treatments (Fig. 6D).
Identification of chemical constituents in extract by LCMS
The EECV possesses different types of organic com-
pounds including Cecropiacic acid, briarellin-A, 
Platycodigenin, Martiriol, Ergost-7-ene-2,3,5,6,9,11,19-
heptol, Gingerglycolipid-A, gingerglycolipid-B, gingerg-
lycolipid-C (Fig. 7).
Discussion
Adipocyte differentiation is a process in which pre-adi-
pocyte are developing into mature spherical shape adipo-
cyte which contains more lipids. At the time of adipocyte 
differentiation, morphological, biochemical characters 
and lipid accumulation were altered [18].
Natural marine sources have more attraction and atten-
tion as pharmacological sources which can be used to 
develop novel therapeutic agents because of distinct 
environments of marine life and biological diversity of 
marine organisms [19]. Many marine compounds pos-
sess the different pharmacological application in terms 
of antibacterial, antidiabetic, anti-inflammatory anti-
viral and antifungal activities [20, 21]. In addition, some 
of the triterpenoid, and saponin has the ability to pro-
motes adipocyte differentiation [22–24]. In the present 
study, we investigated the ability of the ethanolic extract 
of C. vulgaris to enhance the adipocyte differentiation 
Fig. 2 EECV on adipocytes differentiation and glycerol release. A Differentiation spots in the experimental adipocytes on the 10th day, B oil red O 
staining of lipids in experimental adipocytes, C oil red O stained lipid accumulation extracted by 100 % isopropanol. D Glycerol releases from dif-
ferentiated adipocytes on the10th day. The results represent the mean ± SEM of six replicates. Different letters a, b, c, d, within a treatment indicates 
significant differences (p < 0.05)
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and lipid accumulation as promising therapeutic agents 
for dyslipidemia and type-2 diabetes. EECV treatment 
increased lipid droplets accumulation as compared with 
control cells which indicate positive regulation of adipo-
genesis and lipogenesis by the EECV. Further, LC–MS 
results revealed that EECV had few di, triterpenoids 
(Cecropiacic acid; Briarellins–A; Martiriol) and saponin 
(platycodigenin). It might be a reason for accumulation of 
lipid in adipocytes.
Further, we investigated the impact of EECV on the 
key transcriptional factors such as PPARγ and C/EBP-α, 
because of PPARγ and C/EBP-α are much important fac-
tors which are working sequentially and co-operatively in 
stimulating adipogenesis events which lead to accumula-
tion of lipids in the adipocyte [25]. Especially, C/EBP-α 
has distinct functions in adipocyte differentiation and 
insulin sensitivity [26]. C/EBP-α plays a major role in the 
activation and maintenance of PPARγ expression dur-
ing the adipocyte differentiation. In addition, C/EBP-α 
stimulates the gene expressions which are involved in 
the insulin sensitivity, lipogenesis, lipolysis and another 
encoding gene [27, 28]. Our research findings indicates 
Fig. 3 Impact of EECV on adipogenic and lipogenic mRNA expression quantified by qPCR. EECV treatment increased PPAR-γ2, C/EBP-α, adiponec-
tin, FAS and leptin mRNA expression in a dose dependent manner on the 5th and 10th day of differentiation. The results represent the mean ± SEM 
of six replicates. Different letters a, b, c, d, within a treatment indicates significant differences (p < 0.05)
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that the increased expression of PPARγ2 stimulate the 
adipocyte differentiation continuously in EECV treated 
adipocyte by direct acting on C/EBP-α. Similarly, extract 
from Italian rye grass [29] and Mulberry leaf [30] stimu-
lates the adipocyte differentiation through activation of 
PPARγ and C/EBP-α.
Adiponectin is an important hormone that synthesized 
and expressed exclusively in the differentiated adipocyte. 
Adiponectin level was increased in the fully differentiated 
adipocyte. It regulates numbers of metabolic processes 
either by enhancing insulin sensitivity in muscle and liver 
or by stimulating fatty acid oxidation in many tissues 
[31–33]. Over-expression of adiponectin enhances insu-
lin sensitivity in part through hepatic glucose production 
[34]. Increase of adiponectin mRNA expression in the 
adipocyte is one of the main criteria for lipid accumula-
tion in the adipocyte. Our finding strongly supports the 
above said suggestion, in that EECV treatment increased 
lipid droplet and glycerol accumulation in adipocyte may 
be due to increasing of adiponectin.
Leptin is a peptide hormone which is exclusively 
secreted in adipocyte and it has many biological activi-
ties such as effects on appetite, food intake, body weight 
regulation, fertility, reproduction and hematopoiesis 
[35]. Leptin mRNA is stimulated during adipocyte con-
versions, which are useful for studying adipocyte differ-
entiation and their function under controlled conditions 
[36]. The present study, adipocyte supplemented with dif-
ferent concentration of EECV upregulates leptin mRNA 
expression. This result was strongly concurred with lipid 
accumulation report, which reveals EECV treatments 
increased lipid accumulation, because leptin enhance the 
lipid accumulation in adipocyte [37].
Fatty acid synthase (FAS) a multi-enzyme protein, plays 
a vital role in the anabolic conversion of dietary carbo-
hydrates to fatty acids and regulation of lipid metabolism 
[32, 38]. Fatty acid synthase promotes the synthesis of 
triglyceride and cytoplasmic accumulation in the adi-
pocyte [39]. The expression of PPARγ and C/EBP-α are 
much important for activation of other adipocyte specific 
genes and adipokines such as FAS, leptin, and adiponec-
tin [40, 41]. Among these, fatty acid synthase is a lipo-
genic enzyme which involves in the fatty acid synthesis 
and it’s largely upregulated in the cells or tissues [42]. The 
3T3-L1 pre-adipocyte are differentiated with IBMX and 
dexamethasone and acquire the characteristic of fat cells 
Fig. 4 Effects of EECV on PPAR-γ2, C/EBP-α and AMPK-α protein expression. EECV treatment upregulates PPAR-γ2, C/EBP-α and downregulates 
AMPK-α protein level on the 10th day. The results represent the mean ± SEM of three replicates different letters a, b, c, within a treatment indicates 
significant differences (p < 0.05)
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including responsiveness to insulin and induction of FAS 
[43]. The present study, we demonstrated that 3T3-L1 cell 
treated with different concentration of EECV increased 
expression of FAS mRNA as compared with control cells. 
This result suggested that the EECV has lipogenic activity 
by activating FAS mRNA expression.
The AMP-activated protein kinase (AMPK) plays an 
important role in metabolic energy homeostasis in cells. 
When it activated, it switches on the catabolic pathways 
and simultaneously switches off the ATP consuming ana-
bolic pathways [44]. AMPK-α provides an upstream signal 
of peroxisome proliferator-activated receptor γ (PPAR γ), 
which inhibits the adipocyte differentiation [45, 46]. In 
addition, AMPK directly modulates fatty acid synthesis 
and oxidation by changing expression patterns of proteins 
and enzymes, which involved in the fat metabolism and 
also AMPK-α regulates pre-adipocyte differentiation [41, 
47]. Many reports claimed that the AMPK-α pathway is 
responsible for the inhibition of adipocyte differentiation 
by several natural compounds like apigenin dioxinodehy-
droeckol, Chitin, Ginsenoside, epigallocatechin gallate, 
5-Aminoimidazole-4-carboxamide-1-β-D-ribo-furanoside 
(AICAR) [48–53]. The present study, EECV decreased the 
AMPK-α and increased expression of PPAR γ2 during dif-
ferentiation, whereas addition of metformin is an agonist 
for AMPK-α exhibited downregulation of PPAR γ2 in the 
adipocyte. Further, metformin mediated AMPK-activation 
in adipocyte was inhibited by EECV treatment. It indicates 
that EECV increased the adipocyte differentiation and 
lipid accumulation via up-regulation of PPAR γ2 by the 
inhibition AMPK-α expression.
Thiazolidinediones (TZDs) is types of insulin sensi-
tizing drugs used for type 2 diabetes treatments and it 
ameliorate insulin resistance by promoting the adipo-
cyte proliferation and differentiation through up-regu-
lation of PPAR-γ in the adipocyte. Further, it stimulates 
the adiponectin secretion in obesity animal model and 
humans [54, 55] which activating the gene responsible 
for adipocyte differentiation.27 muscle and adipose tis-
sue possess the two kinds of glucose transporter such as 
GLUT-1 and GLUT-4 in which GLUT-4 is an important 
insulin regulator [56]. Down-regulation of glucose uptake 
in muscle and adipose tissue is an important reason for 
insulin resistance in type2 diabetes mellitus patients [57]. 
Fig. 5 Comparative effects between metformin and EECV on AMPK-α and PPAR-γ2. A EECV and metformin alone treated adipocytes exhibited 
down and upregulation of AMPK-α and PPAR-γ2 respectively. B Adipocyte treated with metformin (MF) for 48 h, and then treated with EECV for 
8 days. Metformin mediated activation of AMPK-α was disturbed by the EECV treatment. The results represent the mean ± SEM of three replicates 
different letters a, b, c, d, within a treatment indicates significant differences (p < 0.05)
Page 7 of 11Ilavenil et al. Biol Res  (2016) 49:38 
The present study, troglitazone treatment stimulates the 
adiponectin, PPAR-γ, and GLUT-4 mRNA expression 
in the adipocyte. We found almost similar magnitude 
responses in EECV treatment; it stimulates the adiponec-
tin, PPAR-γ, and GLUT-4 expression. Further, the EECV 
enhances the glucose utilization in adipocyte through up-
regulation of adiponectin and GLUT-4 expression. Gen-
erally, GLUT-4 involved in transporting of glucose into 
adipose tissue and muscle [58]. These data suggested that 
EECV increased glucose utilization in the adipose tissues 
via activation of adiponectin and GLUT-4 expression.
Conclusions
Type-2 diabetes mellitus is closely associated with adipo-
cyte differentiation. Insufficient adipocyte differentiation 
is one of the main reasons for developing type-2 diabe-
tes. Any deficiency in the adipocyte differentiation causes 
fat depositions in the liver and muscle which are making 
Fig. 6 EECV partially mimics like troglitazone. A PPAR-γ2, adiponectin (adipoQ) and GLUT-4mRNA expression up regulated by the EECV (25 μg/
ml) and troglitazone (TZD) (5 μM). B PPAR-γ2 and adiponectin protein expression in control and experimental adipocytes. C Lipid accumulation 
in experimental adipocytes, D glucose utilization in differentiated adipocytes by TZD (5 μM), insulin (1 μg/ml), and EECV (25 μg/ml). The results 
represent the mean ± SEM of six replicates.*p < 0.05 compared to control adipocytes. Different letters a, b, c, within a treatment indicates significant 
differences (p < 0.05)
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insulin resistance and type-2 diabetes. The data presented 
in this study indicate that C. vulgaris effectively activate 
the adipocyte differentiation and glucose utilization. Fur-
ther, we identified some of the triterpenoids and saponin 
compounds in this extract, which may be responsible for 
the positive regulation of adipogenesis. Hence, the pre-
sent findings suggested that the EECV effectively modu-
lates the lipid accumulation and differentiation in 3T3-L1 
cells through AMPK-α mediated signalling pathway. Fur-
ther, investigation needs to determine its active adipo-
genic molecule present in the C. vulgaris.
Methods
Chemicals and cell
The 3T3-L1 preadipocyte was obtained from the Ameri-
can Type Culture Collection (Rockwille, MD, USA). Dul-
becco modified Eagle medium (DMEM) and fetal bovine 
serum was procured from Gibco-BRL (Gaithersburg, MD, 
USA). The EZ-Cytox kit, mRNA extraction and RT-PCR 
kits were purchased from Invitrogen (iTSBiO. Seoul, South 
Korea and Carlsbad, CA, USA). IBMX, Dexamethasone, 
Insulin, troglitazone, oil red O stain, isopropanol and for-
malin were purchased from sigma Aldrich, USA).
Extract preparation
The C. vulgaris powder purchased from Daesang, Seoul, 
South Korea and it was soaked in 70 % ethanol for 72 h 
at 37  °C by intermittent mixing using an orbital shaker. 
After that, the mixture was filtered using Whatman filter 
paper to separate the supernatant and the sediment. The 
filtrate was concentrated under reduced pressure at 40 °C 
until extraction solvent was completely removed, stored 
in refrigerator at 4 °C for further experiments.
Cytotoxicity assay
The water soluble tetrazolium [WST; 2[2-Methoxy-4- 
nitrophenyl]-3[4-Nitrophenyl]-5-[2, 4-disulfophenyl]-2-H-
tetrazolium monosodium salt (EZ-Cytox kit) was used 
for analysis of cytotoxicity. The cells were seeded in the 96 
well at a density of 1 × 104 cells/well. After, 24 h, cells were 
exposed to the different concentration of EECV 5, 10, 15, 
20, 25, 50 and 100 µg/ml]. It was incubated at the 37 °C in 
Fig. 7 Chemical constituents analysis of extract by LC–MS. A Cecropiacic acid, B briarellin-A, C platycodigenin, D martiriol, E Ergost-7-ene-
2,3,5,6,9,11,19-heptol, F ginger glycolipid-A, G ginger glycolipid-B, H ginger glycolipid-C
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5 % CO2 incubator for 48 h and then the culture was treated 
with WST incubated for 2 h. Then, the intensity of colour 
was measured at 450 nm using spectra count ELISA reader 
(Packard Instrument Co., Downers Grove, IL, USA).
Cell culture and experiment
Adipocyte differentiation experiment was carried out by 
the method of Choi et al. [59] with a slight modification. 
Briefly, 3T3-L1 cells were seeded in 12 well culture plates 
at a density of 1.5 × 104 cells/well. Cells were incubated 
at 37 °C with 5 % CO2 and culture medium was replaced 
by every 48 h. After 2 days of 100 % confluence of 3T3-L1 
cells, the growth media was replaced by differentiation 
media (DMEM containing 10 % FBS, 0.5 mM 3-isobutyl-
1-methylxanthine, 1  μM dexamethasone, and 1.7  μM 
insulin) for 48 h. The pre-adipocyte were maintained and 
re-fed every 48  h with 10  % FBS-DMEM medium. To 
examine the effect of EECV on adipocyte differentiation, 
the pre adipocyte received 5, 10, 15, 20 and 25  µg/ml 
EECV (in DMEM medium) every 2 days started at 2 days 
post confluence until the end of the experiment days.
Quantification of lipid content by oil red O staining 
method
3T3-L1 cells were fixed with 10  % formalin for 1  h. The 
cells were then rinsed with 40 % isopropanol and 3 ml of oil 
red O staining solution was added to each well, and incu-
bated at room temperature for 15  min and then washed 
thrice with distilled water and photographed by an inverted 
microscope (CKX41, Olympus Corporation, Tokyo Japan). 
Additionally, oil red O stain was eluted from the adipocyte 
using isopropanol (100 %) and measured at 490 nm [59].
Measurement of glycerol accumulation
According to adipolysis assay Kit procedure (CHEMI-
CONH International Inc. Temecula, CA, USA), the 
glycerol level was quantified. In detail, differentiated 
adipocyte in the presence of different concentration of 
EECV was washed twice with PBS (Gibco, Thermofisher 
scientific, Seoul, South Korea) and further incubated with 
lipolysis buffer for 1 h. Then, the buffer was collected and 
measured the glycerol concentration using microplate 
reader at 540 nm. The amount of glycerol was calculated 
using the standard curve of glycerol.
Glucose utilization
The differentiated adipocyte was exposed to high glucose 
(25 mM) containing DMEM medium with EECV (25 μg/
ml), insulin (1  μg/ml) and troglitazone (5  μM), individ-
ually for 24  h. An assay, without EECV was considered 
as control. After 24  h, the concentration of glucose in 
spent medium was estimated with a commercial assay kit 
(Sigma Aldrich-GAGO-20).
Quantification of adipogenic gene expression using 
quantitative RT‑PCR
Cellular RNA was isolated from 3T3-L1 cells using the 
RNeasy lipid tissue mini kit (Qiagen, Valencia, CA, USA) 
according to the manufacture instructions. Isolated cel-
lular RNA was measured by UVS-99 micro volume UV/
Vis spectrometer-ACT gene (ACTGene, Piscataway, NJ, 
USA). Five hundred nanogram of the cellular RNA was 
used for cDNA synthesis with oligo primer (dT) and 
reverse transcriptase (superscript III first strand synthe-
sis system for RT-PCR)-Invitrogen. Real-time PCR was 
conducted using an ABI 7500 PCR system (Applied Bio-
system, Foster City, CA, USA). The levels of target gene 
cDNA were measured by SYBR green-based real time 
PCR in 10 μl of 5 μl Power SYBR green-based mix reac-
tion buffer (Biorad, Seoul, South Korea), 10 pΜ of for-
ward (F) reverse (R) primers, 1 μL cDNA and 3 μL DEPC 
water. All the expression levels were normalized to the 
housekeeping gene.
Protein extraction and immune blot analysis
Proteins from experimental adipocyte were extracted 
by RIPA lysis buffer with 1X protease inhibitor cock-
tail (Roche, Basel, Switzerland). The cells were washed 
with PBS for thrice. Then, added 500 μl RIPA lysis buffer 
and incubated at 4 °C for five min. After that, cells were 
scraped rapidly with a cells scrapper to remove and lyse 
residual cells and transferred cell lysate to a tube for 
centrifugation at 4 °C for 10 min. The total protein con-
centration was measured by a Bio-Rad protein assay kit. 
An equal amount of protein samples were separated by 
SDS-PAGE (10 %) and trans blotted onto polyvinylidene 
difluoride (PVDF) membranes (iBlot gel transfer stacks, 
Novex, Life Technology, Waltham, MA, USA). According 
to western breeze chemiluminescence protocol (Invitro-
gen, USA), the immunobloting was performed (except 
primary antibody incubation time and temperature) with 
rabbit monoclonal antibody of specific proteins such as 
PPRAγ2, C/EBP-α, adiponectin, AMPK-α and β-actin 
(Cell Signaling Technology, Danvers, MA, USA). The 
signals were observed with an enhanced chemilumines-
cence kit (Biorad, Seoul, South Korea) by a chemilumi-
nescence imaging system (Davinch Chemiluminescence, 
Seoul, South Korea) and the intensity of immune reacted 
bands was quantified by the ImageJ software-1.49 version 
(32 bit), Wayne Rasband, National Institute of Health, 
USA.
LC–MS/MS analysis
The chemical constituents of EECV were analyzed 
by An API 4000 Q TRAP tandem mass spectrometer 
(Applied Biosystems, Foster City, CA, USA), equipped 
with an Agilent 1200 series HPLC system (Agilent 
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Technologies) and with an electrospray ionization tan-
dem mass spectrometry (ESI–MS/MS) source in posi-
tive ion mode [[M  +  H]+]. The analytical conditions 
are: start (100 amu), stop (1300 amu), and scan time 
(4.8  s); curtain gas, 20 psi (N2); heating gas tempera-
ture, 550  °C; nebulising gas, 50 psi; heating gas, 50 psi; 
ion spray voltage, 5500 V; declustering potential, 100 V; 
entrance potential, 10 V.
Statistical analysis
Each experiment was carried out in replicates (n  =  6; 
n =  3). Data are expressed as mean and standard error 
of mean (SEM). Statistical analysis was carried out using, 
Excel and one way ANOVAs and multivariate compari-
sons using the statistical package of social science (SPSS) 
program [Version 16.0] (SPSS, Inc., Chicago, IL, USA) 
and significance were represented as p < 0.05.
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